Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Legal & Regulatory News, In Brief

Executive Summary

Merck, SciClone join companies under Foreign Corrupt Practices Act investigation: Merck and SciClone reported in recent 10-Q filings with the Securities and Exchange Commission that the Department of Justice and the SEC are investigating their activities overseas to determine if they were in compliance with the Foreign Corrupt Practices Act. Merck said the DoJ and SEC are seeking information about its activities in a number of countries and SciClone said the agencies are investigating the "sale, licensing and marketing of its products in foreign countries, including China." Last year several companies, including Lilly, Bristol-Myers Squibb and AstraZeneca, reported they were under investigation for possible violations of the FCPA, which prohibits U.S. companies from bribing foreign officials for government contracts and other business (1"The Pink Sheet," Aug. 31, 2009)

You may also be interested in...

Effectiveness Of Priority Review Voucher, Orphan Status Part Of Tropical Disease Hearing

September public hearing will continue FDA's look into rare and neglected disease drug development.

Pharma Sales Reps May Get Overtime After Appeals Court Defers To Department Of Labor

Novartis plaintiffs seek at least $100 million in overtime; Second Circuit's ruling may impact similar suits against more than a dozen other companies.

U.S. Department of Labor Supports Novartis Sales Reps In Their Overtime Suit

The federal government says a district court erred in finding sales reps are outside sales persons exempt from overtime pay requirements.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts